Pan-Arab consensus statement on the use of botulinum toxin type A in spasticity management

MS Aldosari, SA Bohlega, MA Al-Jadid… - Neurosciences …, 2007 - nsj.org.sa
Special Communication tendon jerks, resulting from hyperexcitability of the stretch reflex.” 1
Spasticity can produce impairment of active functions performed by the patient such as …

Use of botulinum toxin type A in management of adult spasticity: a European consensus statement

AB Ward, M Aguilar, Z De Beyl… - European Journal of …, 2004 - search.proquest.com
There has been a considerable increase over the last few years in the use of botulinum toxin
type A in the treatment of adults with spasticity. It is considered the pharmacological …

The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment …

JA Baker, G Pereira - Clinical Rehabilitation, 2013 - journals.sagepub.com
Objectives: A systematic review and meta-analysis using the Grades of Recommendation,
Assessment, Development and Evaluation (GRADE) approach to evaluate Botulinum Toxin …

[HTML][HTML] Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

J Jacinto, P Varriale, E Pain, A Lysandropoulos… - Frontiers in …, 2020 - frontiersin.org
Results: Two hundred and ten respondents (mean 47.2 years) met screening criteria and
had their responses analyzed. Overall, 43% of respondents had spasticity due to stroke …

12 Clinical Trials of Botulinum Toxin in Adult Spasticity

AE Elia, F Graziella, A Albanese - Botulinum Toxin E-Book …, 2009 - books.google.com
Spasticity is defined as a velocity-dependent increase in stretch reflex activity and is one of
the forms of muscle overactivity that may affect patients with damage to the central nervous …

[PDF][PDF] Use of botulinum toxin type A in management of adult spasticity-a European consensus statement

AB Ward, M Aguilar, ZD Beyl, S Gedin… - Journal of …, 2003 - researchgate.net
There has been a considerable increase over the last few years in the use of botulinum toxin
type A in the treatment of adults with spasticity. It is considered the pharmacological …

Guidelines for the treatment of spasticity in adults using Botulinum toxin

M Aguilar-Barbera, I Bori-Fortuny… - Revista de …, 2004 - europepmc.org
Aims The introduction of Botulinum toxin type A (BTA) in the treatment of spasticity in adults
was a large step forward in neurology and it is currently seen as the first choice treatment in …

[HTML][HTML] Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in spasticity

J Jacinto, P Varriale, E Pain, A Lysandropoulos… - Frontiers in …, 2020 - frontiersin.org
Background: Botulinum toxin-A (BoNT-A) injections are first-line treatment for adult
spasticity. Prior patient surveys have reported that BoNT-A treatment improves quality of life …

Botulinum toxin A in the treatment of spasticity–An open label study

AD Turhanoǧlu, Z Karabulut, H Bayram… - Journal of Back and …, 2002 - content.iospress.com
Purpose: To assess the efficacy of botulinum toxin type A in spasticity in upper-motor neuron
syndromes. Methods: Twenty-three patients with spasticity resulted from stroke-related …

[PDF][PDF] Focal spasticity therapy with botulinum toxin: effects on function, activities of daily living and pain in 100 adult patients

U Bergfeldt, K Borg, K Kullander… - Journal of Rehabilitation …, 2006 - researchgate.net
Objective: Analysis of the effects of a comprehensive focal spasticity program in adult
patients. Design: Retrospective study of an out-patient cohort. Patients: One hundred …